Conference Agenda

09:00

Registration & Refreshment

09:30

Inaugural Ceremony
USA

09:15

Keynote Address: Analyzing the impact of New GDUFA II User Fee Structure

10:50

BREAK

11:00

Five years of Inter Partes Review : Effectiveness and Expectations

12:10

Solving a roadblock: Increasing efficiency while limiting the US Litigation Costs

12:45

Updates on ANDA filing and litigation

01:10

LUNCH

02:00

Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access

02:40

Secondary patents and importance in Indian generics pharma market

03:15

Risk Evaluation and Mitigation Strategies (REMS): Update

03:50

Refreshments and Networking

03:50

Refreshments and Networking

04:15

Patent framework for amplified Biosimilars space : Detailed understanding

04:50

Speed Networking: Benefit from this unique opportunity to meet all the key industry players in quick succession and develop long-term business relationships

05:30

Interactive Discussion: Importance of patent norms and guidelines for generic pharma industry

06:30

Closing remarks from the Chair

06:40

Cocktail Opening Remarks

09:00

Registration

09:30

Opening Remarks by the CHAIR
Europe

09:40

Understanding the Unitary Patent System

10:20

Patent Term Extension and Supplementary Protection Certificate regime (SPCs)

11:00

Break

11:30

Implications of IP enforcement on trademarks on Indian exports

12:30

Biosimilars litigation in Europe

12:50

Implications of Brexit on Indian pharma companies

01:30

LUNCH
SOUTH AFRICA / RUSSIA  

02:30

Patent system and litigation strategies in South Africa
MIDDLE EAST

03:10

Understanding the Middle Eastern patent landscape
AUSTRALIA / NEW ZEALAND  

03:50

Patent protection in Australia & New Zealand and Opening the way for biosimilar versions

04:30

Break

05:30

Moot Court: A simulated court experience where a pharma patent litigation case law would be discussed

06:30

Closing Remarks by the CHAIR

06:45

Cocktail Opening Remarks

09:00

Registration

09:30

Recap and remarks by the CHAIR
India

09:45

Keynote Address

10:20

PANEL DISCUSSION: Regulations and Current price ceiling mechanism

11:15

BREAK

11:30

Addressing Compulsory Licensing Issue

12:10

Accelerating Clinical Trials and Pharmaceutical Regulatory Affairs

12:50

LUNCH
Japan

01:50

The Long Road : Meeting Japanese IP Standards
China

02:15

Paving the way for

02:45

World Café : Join together in smaller groups with your industry colleagues and debate over latest patent cases hitting the newspaper headlines across the globe
Brazil / Mexico /Russia      

03:30

Amendments in patent law and recent patent infringement case laws
SOUTH ASIAN REGIONS  

04:10

Opportunities for India in Indonesian Pharmaceutical Market

04:45

Closing Remarks by the CHAIR

05:00

End of the conference